Natco Pharma

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue1,3911,463705.40816.90794.40
Expenses818.70849.30544.30672.80608.80
EBITDA632.70679.20216.80205.40245.70
Operating Profit575.10626.80170.60155.00198.60
Profit Before Tax571.90613.70161.10144.10185.60
Net Profit480.30517.90140.40233.30122.20
Financial Ratios
Operating Profit Margin47.61%49.83%33.49%27.79%33.42%
Net Profit Margin36.17%38.03%23.40%36.25%28.09%
Earning Per Share (Diluted)26.8428.948.4614.9611.53
Dividends Per Share2.001.501.500.000.00